UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000019872
Receipt number R000022812
Scientific Title Relationship between Mitochondrial DNA Damage and Atherosclerosis
Date of disclosure of the study information 2015/11/20
Last modified on 2019/05/24 18:39:49

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Relationship between Mitochondrial DNA Damage and Atherosclerosis

Acronym

Mitochondrial DNA Damage and Atherosclerosis

Scientific Title

Relationship between Mitochondrial DNA Damage and Atherosclerosis

Scientific Title:Acronym

Mitochondrial DNA Damage and Atherosclerosis

Region

Japan


Condition

Condition

Healthy volunteer, patietns with hypertension, dyslipidemia, diabetes, chronic kidney disease, peripheral artery disease, coronary heart disease, cerebrovascular disease, or heart failure, and current smoker.

Classification by specialty

Cardiology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To investigate the association of mtDNA damage level with conventional cardiovascular risk factors such as hypertension, diabetes, and dyslipidemia to determine whether mtDNA damage level is a useful marker of atherosclerosis.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Confirmatory

Trial characteristics_2

Pragmatic

Developmental phase

Not applicable


Assessment

Primary outcomes

(1)The association between mtDNA damage level and conventional cardiovascular risk factors.
(2) The association between mtDNA damage level and endothelial function.

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Healthy volunteer, patients with hypertension, dyslipidemia, diabetes, chronic kidney disease, peripheral artery disease, coronary artery diesase, cerebrovascular disease or heart failure, and current smoker.

Key exclusion criteria

Patients who are considered not eligible for the study by the attending doctor.

Target sample size

1000


Research contact person

Name of lead principal investigator

1st name Yukihito
Middle name
Last name Yukihito

Organization

Research Institute for Radiation Biology and Medicine, Hiroshima University

Division name

Department of Cardiovascular Regeneration and Medicine

Zip code

734-8551

Address

1-2-3 Kasumi, Minami-ku, Hiroshima

TEL

082-257-5831

Email

yhigashi@hiroshima-u.ac.jp


Public contact

Name of contact person

1st name Tatsuya
Middle name
Last name Tatsuya

Organization

Hiroshima University

Division name

Department of Cardiovascular Medicine, Graduate School of Biomedical & Health Sciences

Zip code

734-8551

Address

1-2-3 Kasumi, Minami-ku, Hiroshima

TEL

082-257-5540

Homepage URL


Email

55maruchin@gmail.com


Sponsor or person

Institute

Department of Cardiovascular Regeneration and Medicine, Research Institute for Radiation Biology and Medicine, Hiroshima University

Institute

Department

Personal name



Funding Source

Organization

Department of Cardiovascular Regeneration and Medicine, Research Institute for Radiation Biology and Medicine, Hiroshima University

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

IRB of Hiroshima University

Address

1-2-3, Kasumi, Minami-ku, Hiroshima

Tel

082-257-5907

Email

kasumi-kenkyu@office.hiroshima-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2015 Year 11 Month 20 Day


Related information

URL releasing protocol

not released

Publication of results

Unpublished


Result

URL related to results and publications

not released

Number of participants that the trial has enrolled

175

Results

We enrolled 175 subjects. We assessed the associations of mtDNA with traditional risk factors and flow-mediated vasodilation. However, there was no significant associations between them, indicating that mtDNA may not be useful as a marker of atherosclerosis.

Results date posted

2019 Year 05 Month 24 Day

Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics

Patients with coronary risk factors

Participant flow

We enrolled 175 patients from outpatient clinic.

Adverse events

none

Outcome measures

We assessed the associations of mtDNA with traditional risk factors and flow-mediated vasodilation. However, there was no significant associations between them.

Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Terminated

Date of protocol fixation

2015 Year 09 Month 03 Day

Date of IRB

2015 Year 09 Month 03 Day

Anticipated trial start date

2015 Year 12 Month 01 Day

Last follow-up date

2018 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

(1)Cross-sectional study
(2)We enroll subjects who visit our hospital from December 2015 to March 2018 and meet the inclusion criteria.
(3)We measure mtDNA damage level, endothelial function, blood pressure, lipid profile, and glucose level.


Management information

Registered date

2015 Year 11 Month 20 Day

Last modified on

2019 Year 05 Month 24 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000022812


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name